glp-1 alcohol Anti-Obesity Rx and and Substance Use Disorders Why Might GLP-1 Drugs Reduce

Joshua Silva, MD, is a licensed physician and Medical Director of Potere Health MD

Image Credit: VectorMine / Shutterstock In a recent review published in the British Journal of Pharmacology , the authors reviewed how glucagon-like peptide 1 receptor (GLP-1) agonists may reduce alcohol and drug-seeking behaviors and evaluated their potential as treatments for addictive disorders

Verdict at a Glance Both amycretin and CagriSema are Novo Nordisk programs targeting the same GLP-1 plus amylin dual pathway, but with fundamentally different molecular strategies

A poll released Friday by KFF found that about 1 in 8 adults say they are currently taking a GLP-1 drug to treat a chronic disease, for weight loss or both an increase of 6% since May 2024

Week 25 to 52: Long-term phase

Microdosing semaglutide refers to taking doses of semaglutide that are lower than the doses typically prescribed or studied for weight loss or diabetes management